ACT	adoptive cell therapy
ADCs	antibody-drug conjugated
AP-1	activator protein 1
bFGF	basic fibroblast growth factor
BsAb	bispecific monoclonal antibodies
BCMA	B-cell maturation antigen
BsAb	bispecific antibody
BiTEs	bispecific T cell engagers
BTLA	band T lymphocyte attenuator
CAR-NK	chimeric antigen receptor NK cells
CAR-T	chimeric antigen receptor T cells
CRS	cytokine release syndrome
CTLA-4	cytotoxic T lymphocyte antigen 4
FDA	food and drug administration
GvHD	graft-versus-host disease
HBV	hepatitis B virus
HPV	human papillomavirus
HLA	human leukocyte antigen
iCasp9	inducible Caspase 9
ICI	immune checkpoint inhibitors
IFN	interferon
IL	interleukin
iPSC	induced pluripotent stem cells
LAG-3	lymphocyte activation gene 3 protein
LPD	lipid-protamine-DNA
mAb	monoclonal antibody
MDSCs	myeloid derived suppressor cells
NF-κB	nuclear factor kappa B
mRNA	messenger RNA
OTOTT	on-target-off-tumor-toxicity
OV	oncolytic virus
PD-1	programmed cell death protein
PD-L1	programmed cell death protein and its ligand
scFv	single chain variable fragment
STAT3	signal transducer and activator of transcription 3
TAM	tumor associated macrophages
TGF-β	transforming growth factor beta
TIL’s	tumor-infiltrating lymphocytes
TIM-3	T-cell immunoglobulin domain and mucin domain protein 3
TME	tumor microenvironment
Tregs	regulatory T cells
TIGIT	T-cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain
TNF	tumor necrosis factor
TRAIL	TNF related apoptosis inducing ligand
VEGF	vascular endothelial growth factor